Louisiana Speech-Language-Hearing Association

 

Home
Up

Audiological Services Committee

Contact: Sherry Weber-Mouton, Director of Audiological Services


1. Co-sponsors Needed for Early Hearing Detection and Intervention
Ensure that Young Children with Hearing Loss Have Access to Early Intervention Services               
             
Please contact your U.S. Senators and urge them to co-sponsor the Early Hearing Detection and Intervention (EHDI) Act of 2007, S. 1069. This important legislation would reauthorize EHDI grants to states, which fund state-wide programs that screen newborns for hearing loss before they leave the hospital. Additionally, the legislation would expand states' ability to enroll identified babies in early intervention programs.

http://takeaction.asha.org/asha2/issues/alert/alertid=11249571&PROCESS=Take+Action

2. Co-Sponsors Needed for Direct Access to Audiologists Legislation
Allow Medicare Beneficiaries to Go Directly to an Audiologist
The "Medicare Hearing Health Care Enhancement Act of 2007" would allow Medicare beneficiaries the option of going directly to a qualified audiologist for hearing and balance diagnostic tests without first having to seek a physician referral.

http://takeaction.asha.org/asha2/issues/alert/?alertid=10549306

3. Co-Sponsors Needed for the Hearing Aid Assistance Tax Credit
Urge Your Legislators to Co-Sponsor H.R. 2329 and S. 1410
Please ask your Representative and Senators to co-sponsor the Hearing Aid Assistance Tax Credit Act, H.R. 2329 and S. 1410, respectively. This legislation would provide a tax credit of up to $500 per hearing aid, once every five years, for parents purchasing a hearing aid for a dependent child or for persons over 55.

http://takeaction.asha.org/asha2/issues/alert/?alertid=9909731


Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs

 

The following are highlights of updates made since the 2000 JCIH statement:

    1. Definition of targeted hearing loss

        • The definition has been expanded from congenital permanent bilateral, unilateral sensory, or permanent conductive hearing loss to include neural hearing loss (eg, "auditory neuropathy/dyssynchrony") in infants admitted to the NICU.

    2. Hearing-screening and -rescreening protocols

        • Separate protocols are recommended for NICU and well-infant nurseries. NICU infants admitted for more than 5 days are to have auditory brainstem response (ABR) included as part of their screening so that neural hearing loss will not be missed.

        • For infants who do not pass automated ABR testing in the NICU, referral should be made directly to an audiologist for rescreening and, when indicated, comprehensive evaluation including ABR.

        • For rescreening, a complete screening on both ears is recommended, even if only 1 ear failed the initial screening.

        • For readmissions in the first month of life for all infants (NICU or well infant), when there are conditions associated with potential hearing loss (eg, hyperbilirubinemia that requires exchange transfusion or culture-positive sepsis), a repeat hearing screening is recommended before discharge.

    3. Diagnostic audiology evaluation

        • Audiologists with skills and expertise in evaluating newborn and young infants with hearing loss should provide audiology diagnostic and auditory habilitation services (selection and fitting of amplification device).

        • At least 1 ABR test is recommended as part of a complete audiology diagnostic evaluation for children younger than 3 years for confirmation of permanent hearing loss.

        • The timing and number of hearing reevaluations for children with risk factors should be customized and individualized depending on the relative likelihood of a subsequent delayed-onset hearing loss. Infants who pass the neonatal screening but have a risk factor should have at least 1 diagnostic audiology assessment by 24 to 30 months of age. Early and more frequent assessment may be indicated for children with cytomegalovirus (CMV) infection, syndromes associated with progressive hearing loss, neurodegenerative disorders, trauma, or culture-positive postnatal infections associated with sensorineural hearing loss; for children who have received extracorporeal membrane oxygenation (ECMO) or chemotherapy; and when there is caregiver concern or a family history of hearing loss.

        • For families who elect amplification, infants in whom permanent hearing loss is diagnosed should be fitted with an amplification device within 1 month of diagnosis.

    4. Medical evaluation

        • For infants with confirmed hearing loss, a genetics consultation should be offered to their families.

        • Every infant with confirmed hearing loss should be evaluated by an otolaryngologist who has knowledge of pediatric hearing loss and have at least 1 examination to assess visual acuity by an ophthalmologist who is experienced in evaluating infants.

        • The risk factors for congenital and acquired hearing loss have been combined in a single list rather than grouped by time of onset.

    5. Early intervention

        • All families of infants with any degree of bilateral or unilateral permanent hearing loss should be considered eligible for early intervention services.

        • There should be recognized central referral points of entry that ensure specialty services for infants with confirmed hearing loss.

        • Early intervention services for infants with confirmed hearing loss should be provided by professionals who have expertise in hearing loss, including educators of the deaf, speech-language pathologists, and audiologists.

        • In response to a previous emphasis on "natural environments," the JCIH recommends that both home-based and center-based intervention options be offered.

    6. Surveillance and screening in the medical home

        • For all infants, regular surveillance of developmental milestones, auditory skills, parental concerns, and middle-ear status should be performed in the medical home, consistent with the American Academy of Pediatrics (AAP) pediatric periodicity schedule. All infants should have an objective standardized screening of global development with a validated assessment tool at 9, 18, and 24 to 30 months of age or at any time if the health care professional or family has concern.

        • Infants who do not pass the speech-language portion of a medical home global screening or for whom there is a concern regarding hearing or language should be referred for speech-language evaluation and audiology assessment.

    7. Communication

        • The birth hospital, in collaboration with the state EHDI coordinator, should ensure that the hearing-screening results are conveyed to the parents and the medical home.

        • Parents should be provided with appropriate follow-up and resource information, and hospitals should ensure that each infant is linked to a medical home.

        • Information at all stages of the EHDI process is to be communicated to the family in a culturally sensitive and understandable format.

        • Individual hearing-screening information and audiology diagnostic and habilitation information should be promptly transmitted to the medical home and the state EHDI coordinator.

        • Families should be made aware of all communication options and available hearing technologies (presented in an unbiased manner). Informed family choice and desired outcome guide the decision-making process.

    8. Information infrastructure

        • States should implement data-management and -tracking systems as part of an integrated child health information system to monitor the quality of EHDI services and provide recommendations for improving systems of care.

        • An effective link between health and education professionals is needed to ensure successful transition and to determine outcomes of children with hearing loss for planning and establishing public health policy.

The entire Year 2007 Statement can be viewed at:
http://www.asha.org/docs/html/PS2007-00281.html


 

Contact US: LSHA; 8550 United Plaza Blvd.; Suite 1001; Baton Rouge, LA 70809; (225) 922-4512; Fax: (225) 922-4611; Email: lsha@pncpa.com